Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2 open-label trial of ATI-50002 Topical for the treatment of Alopecia Areata (AA).

Trial Profile

A Phase 2 open-label trial of ATI-50002 Topical for the treatment of Alopecia Areata (AA).

Recruiting
Phase of Trial: Phase II

Latest Information Update: 03 Aug 2018

At a glance

  • Drugs ATI 502 (Primary)
  • Indications Alopecia areata
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Aug 2018 According to an Aclaris Therapeutics media release, interim data from this trial has been presented in the company media release.
    • 12 Mar 2018 According to an Aclaris Therapeutics media release, data is expected to be available in the mid-2018.
    • 07 Nov 2017 Status changed from planning to recruiting, according to an Aclaris Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top